---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-163546"
form_type: "8-K"
ticker: "COGT"
cik: "0001622229"
company_name: "Cogent Biosciences, Inc."
filed_at: "2023-06-08T23:59:59+00:00"
generated_at: "2026-06-14T04:59:38.403324+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cogent Biosciences prices $150M common stock offering of 12.5M shares at $12.00/share

## Summary
- Offers 12,500,000 shares of common stock at $12.00 per share; gross proceeds ~$150M.
- Underwriters granted 30-day option to purchase up to 1,875,000 additional shares on same terms.
- Underwriting syndicate led by J.P. Morgan, Jefferies, Piper Sandler, and Guggenheim Securities.

## SEC filing metadata
- accession: 0001193125-23-163546
- form_type: 8-K
- ticker: COGT
- cik: 0001622229
- company_name: Cogent Biosciences, Inc.
- filed_at: 2023-06-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1622229/000119312523163546/0001193125-23-163546-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1622229/000119312523163546/d518843d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-163546
- JSON: https://secwatch.observer/filing/0001193125-23-163546.json
- Plain text: https://secwatch.observer/filing/0001193125-23-163546.txt

## Key facts
- Material Agreements
  Cogent Biosciences, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC, Jefferies LLC, Piper Sandler & Co. and Guggenheim Securities, LLC, as the representatives of the underwriters valued at $150 million (effective 2023-06-06).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: J.P. Morgan Securities LLC, Jefferies LLC, Piper Sandler & Co. and Guggenheim Securities, LLC, as the representatives of the underwriters
  - Value: $150 million
  - Effective: 2023-06-06
  source text: On June 6, 2023, Cogent Biosciences, Inc. (the “Company”) entered into an underwriting agreement (“Underwriting Agreement”) with J.P. Morgan Securities LLC, Jefferies LLC, Piper Sandler & Co. and Guggenheim Securities, LLC, as the representatives of the underwriters named therein (the “Underwriters”), to issue and sell 12,500,000 shares of the Company’s common stock at a public offering price of $12.00 per share (the “Offering”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1622229/000119312523163546/0001193125-23-163546-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.